| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-03944SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47909-0.1mg | |||
| IHC-Prediluted | NBP2-48362 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-91858-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-43982 | |||
| BSA Free | NBP2-61415-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-86120-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-38479-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-44075 | |||
| BSA Free | NBP2-52975-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-34039-25ul | |||
![Western Blot: IL-27/IL-35 EBI3 Subunit Antibody [NBP2-03944] - Total protein from human HeLa, K562 and mouse Raw264.7 cells was separated on a 4-20% gel by SDS-PAGE, transferred to PVDF membrane and blocked in 5% non-fat milk in TBST. The membrane was probed with 2.0 ug/ml anti-EBI3 in 1% non-fat milk in TBST and detected with an anti-rabbit HRP secondary antibody using chemiluminescence.](http://images.novusbio.com/fullsize/IL-27-IL-35-EBI3-Subunit-Antibody-Western-Blot-NBP2-03944-img0009.jpg "Western Blot: IL-27/IL-35 EBI3 Subunit Antibody [NBP2-03944] - Total protein from human HeLa, K562 and mouse Raw264.7 cells was separated on a 4-20% gel by SDS-PAGE, transferred to PVDF membrane and blocked in 5% non-fat milk in TBST. The membrane was probed with 2.0 ug/ml anti-EBI3 in 1% non-fat milk in TBST and detected with an anti-rabbit HRP secondary antibody using chemiluminescence.")
![Immunohistochemistry-Paraffin: IL-27/IL-35 EBI3 Subunit Antibody [NBP2-03944] - Mouse brain tissue stained with EBI3 antibody at 5 ug/ml.](http://images.novusbio.com/fullsize/IL-27-IL-35-EBI3-Subunit-Antibody-Immunohistochemistry-Paraffin-NBP2-03944-img0008.jpg)
![Immunohistochemistry-Paraffin: IL-27/IL-35 EBI3 Subunit Antibody [NBP2-03944] - Mouse brain tissue using an isotype control (top left) and (bottom left, right) at 5 ug/ml.](http://images.novusbio.com/fullsize/IL-27-IL-35-EBI3-Subunit-Antibody-Immunohistochemistry-Paraffin-NBP2-03944-img0007.jpg)
![Western Blot: Vitronectin Antibody [NBP2-20866] - Proteomics analysis of losartan-mediated reversion of early fibrotic RDEB changes.Bar graph show abundance of representative proteins normalized by losartan treatment. Mean +/- S.E.M. (LFQ intensity) of groups of individual mice (wild-type, untreated, & losartan-treated C7-hypomorphic mice). Unpaired t-test calculated significance. Abundance of Lrg1: *P-value C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.022; abundance of serpin f2: **P-value untreated C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.0084; abundance of vitronectin: **P-value untreated C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.0094. Western blots of skin lysates from wild-type, untreated C7-hypomorphic, & 7-week losartan-treated C7-hypomorphic mice not used for proteomics. Image collected & cropped by CiteAb from the following publication (www.onlinelibrary.wiley.com/doi/10.15252/emmm.201505061) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-Western-Blot-NBP2-20866-img0009.jpg "<b>Biological Strategies Validation. </b>Western Blot: Vitronectin Antibody [NBP2-20866] - Proteomics analysis of losartan-mediated reversion of early fibrotic RDEB changes.Bar graph show abundance of representative proteins normalized by losartan treatment. Mean +/- S.E.M. (LFQ intensity) of groups of individual mice (wild-type, untreated, & losartan-treated C7-hypomorphic mice). Unpaired t-test calculated significance. Abundance of Lrg1: *P-value C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.022; abundance of serpin f2: **P-value untreated C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.0084; abundance of vitronectin: **P-value untreated C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.0094. Western blots of skin lysates from wild-type, untreated C7-hypomorphic, & 7-week losartan-treated C7-hypomorphic mice not used for proteomics. Image collected & cropped by CiteAb from the following publication (www.onlinelibrary.wiley.com/doi/10.15252/emmm.201505061) licensed under a CC-BY license.")
![<b>Biological Strategies Validation. </b>Immunohistochemistry-Paraffin: Vitronectin Antibody [NBP2-20866] - Vitronectin antibody detects Vitronectin protein by immunohistochemical analysis. Sample: Paraffin-embedded human lung cancer. Vitronectin stained by Vitronectin antibody diluted at 1:1000.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-Immunohistochemistry-Paraffin-NBP2-20866-img0008.jpg)
![Immunohistochemistry-Paraffin: Vitronectin Antibody [NBP2-20866] - Human colon carcinoma, using Vitronectin antibody at 1:500 dilution. Antigen Retrieval: Trilogy™ (EDTA based, pH 8.0) buffer, 15min.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-Immunohistochemistry-Paraffin-NBP2-20866-img0003.jpg)
![Western Blot: Vitronectin Antibody [NBP2-20866] - HepG2 whole cell extract and conditioned medium (30 ug) were separated by 10% SDS-PAGE, and the membrane was blotted with Vitronectin antibody (NBP2-20866) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/nbp2-20866_rabbit-polyclonal-vitronectin-antibody-910202420104489.jpg)
![Immunohistochemistry: CD34 Antibody (QBEnd/10 + HPCA1/763) [NBP2-44567] - Representative images of RCC patient biopsies immunostained for VEGFR2, CD34, and NRP1 and counterstained using Hoechst33342. Left column shows examples of NRP1 expressed by endothelial cells; middle column shows a tumor sample with low NRP1 expression. Right column shows NRP1 positive perivascular tumor cells. Blood vessels were stained for CD34 and nuclei counterstained using Hoechst33342. Left column shows cis complexes, localized within the endothelium. Middle column shows a tumor lacking VEGFR2/NRP1 complexes. Right column shows trans complexes, located adjacent to the endothelium (white arrowheads). Image collected and cropped by Citeab from the following publication (Perivascular Neuropilin-1 expression is an independent marker of improved survival in renal cell carcinoma. J Pathol (2020) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/CD34-Antibody-QBEnd-10-+-HPCA1-763-Immunohistochemistry-NBP2-44567-img0005.jpg "Immunohistochemistry: CD34 Antibody (QBEnd/10 + HPCA1/763) [NBP2-44567] - Representative images of RCC patient biopsies immunostained for VEGFR2, CD34, and NRP1 and counterstained using Hoechst33342. Left column shows examples of NRP1 expressed by endothelial cells; middle column shows a tumor sample with low NRP1 expression. Right column shows NRP1 positive perivascular tumor cells. Blood vessels were stained for CD34 and nuclei counterstained using Hoechst33342. Left column shows cis complexes, localized within the endothelium. Middle column shows a tumor lacking VEGFR2/NRP1 complexes. Right column shows trans complexes, located adjacent to the endothelium (white arrowheads). Image collected and cropped by Citeab from the following publication (Perivascular Neuropilin-1 expression is an independent marker of improved survival in renal cell carcinoma. J Pathol (2020) licensed under a CC-BY license.")
![Immunohistochemistry-Paraffin: CD34 Antibody (QBEnd/10 + HPCA1/763) [NBP2-44567] - Human Angiosarcoma stained with CD34 Monoclonal Antibody (QBEnd/10 + HPCA1/763)](http://images.novusbio.com/fullsize/CD34-Antibody-QBEnd-10-+-HPCA1-763-Immunohistochemistry-Paraffin-NBP2-44567-img0001.jpg)
![Immunohistochemistry-Paraffin: CD34 Antibody (QBEnd/10 + HPCA1/763) [NBP2-44567] - Human Colon Carcinoma stained with CD34 Monoclonal Antibody (QBEnd/10 + HPCA1/763)](http://images.novusbio.com/fullsize/CD34-Antibody-QBEnd-10-+-HPCA1-763-Immunohistochemistry-Paraffin-NBP2-44567-img0002.jpg)
![Immunohistochemistry-Paraffin: CD34 Antibody (QBEnd/10 + HPCA1/763) [NBP2-44567] - Human Placenta stained with CD34 Monoclonal Antibody (QBEnd/10 + HPCA1/763)](http://images.novusbio.com/fullsize/CD34-Antibody-QBEnd-10-+-HPCA1-763-Immunohistochemistry-Paraffin-NBP2-44567-img0003.jpg)
![Immunohistochemistry-Paraffin: CD34 Antibody (QBEnd/10 + HPCA1/763) [NBP2-44567] - Human Tonsil stained with CD34 Monoclonal Antibody (QBEnd/10 + HPCA1/763)](http://images.novusbio.com/fullsize/CD34-Antibody-QBEnd-10-+-HPCA1-763-Immunohistochemistry-Paraffin-NBP2-44567-img0004.jpg)
![Immunocytochemistry/Immunofluorescence: Complement Component C1qA Antibody (7H8) [NB200-539] - staining C1q (green) in human SHSY5Y cells by ICC/IF (Immunocytochemistry/immunofluorescence).](http://images.novusbio.com/fullsize/Complement-Component-C1qA-Antibody-7H8-Chromatin-Immunoprecipitation-NB200-539-img0002.jpg "Immunocytochemistry/Immunofluorescence: Complement Component C1qA Antibody (7H8) [NB200-539] - staining C1q (green) in human SHSY5Y cells by ICC/IF (Immunocytochemistry/immunofluorescence).")
![Flow Cytometry: LAG-3 Antibody Pack [NBP3-11743] - Human peripheral blood mononuclear cells (PBMCs) were either untreated (top panel) or treated with with 5 ug/mL PHA (bottom panel) for 5 days. PBMCs were stained with Mouse Anti-Human LAG-3 Monoclonal Antibody (Catalog # MAB23193) followed by Allophycocyanin-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # F0101B) and Mouse Anti-Human CD3 epsilon APC-conjugated Monoclonal Antibody (Catalog # FAB100A). Quadrant markers were set based on isotype control antibody staining (Catalog # MAB002) (data not shown).](http://images.novusbio.com/fullsize/LAG-3-Antibody-Pack-Flow-Cytometry-NBP3-11743-img0001.jpg "Flow Cytometry: LAG-3 Antibody Pack [NBP3-11743] - Human peripheral blood mononuclear cells (PBMCs) were either untreated (top panel) or treated with with 5 ug/mL PHA (bottom panel) for 5 days. PBMCs were stained with Mouse Anti-Human LAG-3 Monoclonal Antibody (Catalog # MAB23193) followed by Allophycocyanin-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # F0101B) and Mouse Anti-Human CD3 epsilon APC-conjugated Monoclonal Antibody (Catalog # FAB100A). Quadrant markers were set based on isotype control antibody staining (Catalog # MAB002) (data not shown).")
![Western Blot: LAG-3 Antibody Pack [NBP3-11743] - Western blot shows lysates of human peripheral blood mononuclear cells (PBMC) untreated or treated (+) with 1 ug/mL PHA for 5 days and HDLM-2 human Hodgkin's lymphoma cell line. PVDF membrane was probed with 2 ug/mL of Mouse Anti-Human LAG-3 Monoclonal Antibody (Catalog # MAB23193) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # HAF018). Specific bands were detected for LAG-3 at approximately 60-75 kDa (as indicated). GAPDH (Catalog # MAB5718) is shown as a loading control.](http://images.novusbio.com/fullsize/LAG-3-Antibody-Pack-Western-Blot-NBP3-11743-img0002.jpg)
![Flow Cytometry: LAG-3 Antibody Pack [NBP3-11743] - Human peripheral blood mononuclear cells (PBMCs) were either untreated (bottom panel) or treated with with 5 ug/mL PHA (top panel) for 5 days. PBMCs were stained with Mouse Anti-Human LAG-3 Monoclonal Antibody (Catalog # MAB23195) followed by Allophycocyanin-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # F0101B) and Mouse Anti-Human CD3 epsilon PE-conjugated Monoclonal Antibody (Catalog # FAB100P). Quadrant markers were set based on isotype control antibody staining (Catalog # MAB003) (data not shown).](http://images.novusbio.com/fullsize/LAG-3-Antibody-Pack-Flow-Cytometry-NBP3-11743-img0003.jpg)
![Flow Cytometry: LAG-3 Antibody Pack [NBP3-11743] - Analysis using the FITC conjugate of NBP1-97657. Tumor infiltrating lymphocytes (TILs) express LAG-3 (detected using LAG-3 (human), mAb (17B4).](http://images.novusbio.com/fullsize/LAG-3-Antibody-Pack-Flow-Cytometry-NBP3-11743-img0005.jpg)
![Western Blot: ECSIT Antibody [NBP1-91858] - Analysis in human cell lines PC-3 and HeLa using Anti-ECSIT antibody. Corresponding ECSIT RNA-seq data are presented for the same cell lines. Loading control: Anti-HSP90B1.](http://images.novusbio.com/fullsize/ECSIT-Antibody-Western-Blot-NBP1-91858-img0013.jpg "<b>Orthogonal Strategies Validation. </b>Western Blot: ECSIT Antibody [NBP1-91858] - Analysis in human cell lines PC-3 and HeLa using Anti-ECSIT antibody. Corresponding ECSIT RNA-seq data are presented for the same cell lines. Loading control: Anti-HSP90B1.")
![<b>Orthogonal Strategies Validation. </b>Immunocytochemistry/Immunofluorescence: ECSIT Antibody [NBP1-91858] - Staining of human cell line U-251 MG shows localization to nucleoplasm & cytosol. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/ECSIT-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-91858-img0010.jpg)
![Immunohistochemistry-Paraffin: ECSIT Antibody [NBP1-91858] - Staining of human colon shows strong cytoplasmic positivity in glandular cells.](http://images.novusbio.com/fullsize/ECSIT-Antibody-Immunohistochemistry-Paraffin-NBP1-91858-img0008.jpg)
![Western Blot: ECSIT Antibody [NBP1-91858] - Analysis in mouse cell line NIH-3T3 and rat cell line NBT-II.](http://images.novusbio.com/fullsize/ECSIT-Antibody-Western-Blot-NBP1-91858-img0011.jpg)
![Western Blot: CTGF/CCN2 Antibody (CL5339) [NBP2-61415] - Analysis in human cell line U-251 MG.](http://images.novusbio.com/fullsize/CTGF-CCN2-Antibody-CL5339-Western-Blot-NBP2-61415-img0007.jpg "Western Blot: CTGF/CCN2 Antibody (CL5339) [NBP2-61415] - Analysis in human cell line U-251 MG.")
![Immunohistochemistry-Paraffin: CTGF/CCN2 Antibody (CL5339) [NBP2-61415] - Staining of rat cerebral cortex shows strong cytoplasmic positivity in layer 6b neurons.](http://images.novusbio.com/fullsize/CTGF-CCN2-Antibody-CL5339-Immunohistochemistry-Paraffin-NBP2-61415-img0013.jpg)
![Immunohistochemistry-Paraffin: CTGF/CCN2 Antibody (CL5339) [NBP2-61415] - Staining of human cerebral cortex shows strong cytoplasmic positivity in layer 6b neurons.](http://images.novusbio.com/fullsize/CTGF-CCN2-Antibody-CL5339-Immunohistochemistry-Paraffin-NBP2-61415-img0008.jpg)
![Immunohistochemistry-Paraffin: CTGF/CCN2 Antibody (CL5339) [NBP2-61415] - Staining of human lymph node shows no positivity in non-germinal center cells as expected.](http://images.novusbio.com/fullsize/CTGF-CCN2-Antibody-CL5339-Immunohistochemistry-Paraffin-NBP2-61415-img0009.jpg)
![Immunohistochemistry-Paraffin: CTGF/CCN2 Antibody (CL5339) [NBP2-61415] - Staining of mouse cerebral cortex shows strong cytoplasmic positivity in layer 6b neurons.](http://images.novusbio.com/fullsize/CTGF-CCN2-Antibody-CL5339-Immunohistochemistry-Paraffin-NBP2-61415-img0010.jpg)
![Immunohistochemistry-Paraffin: CTGF/CCN2 Antibody (CL5339) [NBP2-61415] - Staining of mouse cerebral cortex shows strong cytoplasmic positivity in layer 6b neurons.](http://images.novusbio.com/fullsize/CTGF-CCN2-Antibody-CL5339-Immunohistochemistry-Paraffin-NBP2-61415-img0011.jpg)
![Immunohistochemistry-Paraffin: CTGF/CCN2 Antibody (CL5339) [NBP2-61415] - Staining of rat cerebral cortex shows strong cytoplasmic positivity in layer 6b neurons.](http://images.novusbio.com/fullsize/CTGF-CCN2-Antibody-CL5339-Immunohistochemistry-Paraffin-NBP2-61415-img0012.jpg)
![Immunohistochemistry-Paraffin: STING/TMEM173 Antibody [NBP2-48684] - Staining in human fallopian tube and liver tissues using NBP2-48684 antibody. Corresponding TMEM173 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/STING-TMEM173-Antibody-Immunohistochemistry-Paraffin-NBP2-48684-img0018.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: STING/TMEM173 Antibody [NBP2-48684] - Staining in human fallopian tube and liver tissues using NBP2-48684 antibody. Corresponding TMEM173 RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Western Blot: STING/TMEM173 Antibody [NBP2-48684] - Analysis in human cell line HDLM-2 using STING/TMEM173 Antibody.](http://images.novusbio.com/fullsize/STING-TMEM173-Antibody-Western-Blot-NBP2-48684-img0003.jpg)
![<b>Independent Antibodies Validation. </b>Immunohistochemistry-Paraffin: STING/TMEM173 Antibody [NBP2-48684] - Staining of human fallopian tube, liver, lymph node and prostate using Anti-TMEM173 antibody NBP2-48684 (A) shows similar protein distribution across tissues to independent antibody NBP2-38389 (B).](http://images.novusbio.com/fullsize/STING-TMEM173-Antibody-Immunohistochemistry-Paraffin-NBP2-48684-img0014.jpg)
![Immunohistochemistry-Paraffin: STING/TMEM173 Antibody [NBP2-48684] - Staining of human Fallopian tube shows strong cytoplasmic and membranous positivity in glandular cells.](http://images.novusbio.com/fullsize/STING-TMEM173-Antibody-Immunohistochemistry-Paraffin-NBP2-48684-img0013.jpg)
![Immunohistochemistry-Paraffin: STING/TMEM173 Antibody [NBP2-48684] - Staining of human liver shows no positivity in hepatocytes as expected.](http://images.novusbio.com/fullsize/STING-TMEM173-Antibody-Immunohistochemistry-Paraffin-NBP2-48684-img0015.jpg)
![Immunohistochemistry-Paraffin: STING/TMEM173 Antibody [NBP2-48684] - Staining of human lymph node shows strong membranous positivity in follicular dendritic cells.](http://images.novusbio.com/fullsize/STING-TMEM173-Antibody-Immunohistochemistry-Paraffin-NBP2-48684-img0016.jpg)
![Immunohistochemistry-Paraffin: STING/TMEM173 Antibody [NBP2-48684] - Staining of human prostate shows moderate membranous positivity in basal layer glandular cells.](http://images.novusbio.com/fullsize/STING-TMEM173-Antibody-Immunohistochemistry-Paraffin-NBP2-48684-img0017.jpg)
![Western Blot: SELK Antibody [NBP1-86120] - Analysis in human cell line HepG2.](http://images.novusbio.com/fullsize/SELK-Antibody-Western-Blot-NBP1-86120-img0006.jpg "Western Blot: SELK Antibody [NBP1-86120] - Analysis in human cell line HepG2.")
![Immunocytochemistry/Immunofluorescence: SELK Antibody [NBP1-86120] - Staining of human cell line U-251 MG shows localization to nucleoplasm & cytosol.](http://images.novusbio.com/fullsize/SELK-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-86120-img0007.jpg)
![Immunohistochemistry-Paraffin: SELK Antibody [NBP1-86120] - Staining of human testis shows weak cytoplasmic psoticity in Leydig cells.](http://images.novusbio.com/fullsize/SELK-Antibody-Immunohistochemistry-Paraffin-NBP1-86120-img0011.jpg)
![Immunohistochemistry-Paraffin: SELK Antibody [NBP1-86120] - Staining of human cerebral cortex shows weak cytoplasmic positivity in neurons.](http://images.novusbio.com/fullsize/SELK-Antibody-Immunohistochemistry-Paraffin-NBP1-86120-img0008.jpg)
![Immunohistochemistry-Paraffin: SELK Antibody [NBP1-86120] - Staining of human liver shows no positivity in hepatocytes.](http://images.novusbio.com/fullsize/SELK-Antibody-Immunohistochemistry-Paraffin-NBP1-86120-img0009.jpg)
![Immunohistochemistry-Paraffin: SELK Antibody [NBP1-86120] - Staining of human tonsil shows moderate to strong cytoplasmic positivity in non-germinal center cells.](http://images.novusbio.com/fullsize/SELK-Antibody-Immunohistochemistry-Paraffin-NBP1-86120-img0010.jpg)
![Immunohistochemistry-Paraffin: CD3 epsilon Antibody [NBP2-38479] - Staining in human lymph node and small intestine tissues . Corresponding CD3E RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/CD3-epsilon-Antibody-Immunohistochemistry-Paraffin-NBP2-38479-img0011.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CD3 epsilon Antibody [NBP2-38479] - Staining in human lymph node and small intestine tissues . Corresponding CD3E RNA-seq data are presented for the same tissues.")
![<b>Independent Antibodies Validation and Orthogonal Strategies Validation.</b>Immunohistochemistry-Paraffin: CD3 epsilon Antibody [NBP2-38479] - Staining of human cerebral cortex, lymph node, spleen and tonsil using Anti-CD3E antibody NBP2-38479 (A) shows similar protein distribution across tissues to independent antibody NBP2-38520 (B).](http://images.novusbio.com/fullsize/CD3-epsilon-Antibody-Immunohistochemistry-Paraffin-NBP2-38479-img0012.jpg)
![Western Blot: CD3 epsilon Antibody [NBP2-38479] - Lane 1: Marker [kDa] 250, 130, 95, 72, 55, 36, 28, 17, 10. Lane 2: Human cell line RT-4. Lane 3: Human cell line U-251MG. Lane 4: Human Plasma. Lane 5: Human liver tissue. Lane 6: Human tonsil tissue](http://images.novusbio.com/fullsize/CD3-epsilon-Antibody-Western-Blot-NBP2-38479-img0002.jpg)
![Western Blot: CD3 epsilon Antibody [NBP2-38479] - Staining of human spleen shows weak to moderate cytoplasmic positivity in cells in red pulp.](http://images.novusbio.com/fullsize/CD3-epsilon-Antibody-Western-Blot-NBP2-38479-img0010.jpg)
![Immunohistochemistry-Paraffin: CD3 epsilon Antibody [NBP2-38479] - Staining of human cerebral cortex.](http://images.novusbio.com/fullsize/CD3-epsilon-Antibody-Immunohistochemistry-Paraffin-NBP2-38479-img0013.jpg)
![Immunohistochemistry-Paraffin: CD3 epsilon Antibody [NBP2-38479] - Staining of human lymph node shows weak to moderate cytoplasmic positivity in lymphoid cells.](http://images.novusbio.com/fullsize/CD3-epsilon-Antibody-Immunohistochemistry-Paraffin-NBP2-38479-img0007.jpg)
![Immunohistochemistry-Paraffin: CD3 epsilon Antibody [NBP2-38479] - Staining of human purkinje layer of the cerebellum shows no cytoplasmic positivity as expected.](http://images.novusbio.com/fullsize/CD3-epsilon-Antibody-Immunohistochemistry-Paraffin-NBP2-38479-img0008.jpg)
![Immunohistochemistry-Paraffin: CD3 epsilon Antibody [NBP2-38479] - Staining of human small intestine shows weak to moderate cytoplasmic positivity in lymphoid cells.](http://images.novusbio.com/fullsize/CD3-epsilon-Antibody-Immunohistochemistry-Paraffin-NBP2-38479-img0009.jpg)
![Immunohistochemistry-Paraffin: CD3 epsilon Antibody [NBP2-38479] - Staining of human tonsil.](http://images.novusbio.com/fullsize/CD3-epsilon-Antibody-Immunohistochemistry-Paraffin-NBP2-38479-img0014.jpg)
![Western Blot: CD117/c-kit Antibody (CL1657) [NBP2-52975] - Lane 1: Marker [kDa], Lane 2: Human cell line RT-4](http://images.novusbio.com/fullsize/CD117-c-kit-Antibody-CL1657-Western-Blot-NBP2-52975-img0006.jpg "Western Blot: CD117/c-kit Antibody (CL1657) [NBP2-52975] - Lane 1: Marker [kDa], Lane 2: Human cell line RT-4")
![Immunohistochemistry-Paraffin: CD117/c-kit Antibody (CL1657) [NBP2-52975] - Staining of human stomach shows strong positivity in a subset of lymphoid cells.](http://images.novusbio.com/fullsize/CD117-c-kit-Antibody-CL1657-Immunohistochemistry-Paraffin-NBP2-52975-img0005.jpg)
![Immunohistochemistry-Paraffin: CD117/c-kit Antibody (CL1657) [NBP2-52975] - Staining of human cerebellum shows moderate positivity in neuropil of the molecular layer.](http://images.novusbio.com/fullsize/CD117-c-kit-Antibody-CL1657-Immunohistochemistry-Paraffin-NBP2-52975-img0001.jpg)
![Immunohistochemistry-Paraffin: CD117/c-kit Antibody (CL1657) [NBP2-52975] - Staining of human colon shows strong immunoreactivity in a subset of lymphoid cells.](http://images.novusbio.com/fullsize/CD117-c-kit-Antibody-CL1657-Immunohistochemistry-Paraffin-NBP2-52975-img0002.jpg)
![Immunohistochemistry-Paraffin: CD117/c-kit Antibody (CL1657) [NBP2-52975] - Staining of human pancreas shows absence of immunoreactivity (negative control).](http://images.novusbio.com/fullsize/CD117-c-kit-Antibody-CL1657-Immunohistochemistry-Paraffin-NBP2-52975-img0003.jpg)
![Immunohistochemistry-Paraffin: CD117/c-kit Antibody (CL1657) [NBP2-52975] - Staining of human small intestine shows strong immunoreactivity in a subset of lymphoid cells (macrophages).](http://images.novusbio.com/fullsize/CD117-c-kit-Antibody-CL1657-Immunohistochemistry-Paraffin-NBP2-52975-img0004.jpg)
![Immunohistochemistry-Paraffin: CD8 Antibody [NBP2-34039] - CD8 alpha Antibody [NBP2-34039] - Analysis in human spleen and skeletal muscle tissues. Corresponding CD8A RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/CD8-alpha-Antibody-Immunohistochemistry-Paraffin-NBP2-34039-img0007.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CD8 Antibody [NBP2-34039] - CD8 alpha Antibody [NBP2-34039] - Analysis in human spleen and skeletal muscle tissues. Corresponding CD8A RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CD8 alpha Antibody [NBP2-34039] - Staining of human spleen shows moderate to strong positivity in lymphoid cells.](http://images.novusbio.com/fullsize/CD8-alpha-Antibody-Immunohistochemistry-Paraffin-NBP2-34039-img0003.jpg)
![Immunohistochemistry-Paraffin: CD8 alpha Antibody [NBP2-34039] - Staining of human lymph node shows moderate to strong positivity in lymphoid cells.](http://images.novusbio.com/fullsize/CD8-alpha-Antibody-Immunohistochemistry-Paraffin-NBP2-34039-img0004.jpg)
![Immunohistochemistry-Paraffin: CD8 alpha Antibody [NBP2-34039] - Staining of human small intestine shows moderate to strong positivity in lymphoid cells.](http://images.novusbio.com/fullsize/CD8-alpha-Antibody-Immunohistochemistry-Paraffin-NBP2-34039-img0005.jpg)
![Immunohistochemistry-Paraffin: CD8 alpha Antibody [NBP2-34039] - Staining of human skeletal muscle shows no cytoplasmic positivity as expected.](http://images.novusbio.com/fullsize/CD8-alpha-Antibody-Immunohistochemistry-Paraffin-NBP2-34039-img0006.jpg)